Lupin, Zydus sign licensing pact to co-market Saroglitazar Mg for chronic liver diseases in India
In 2020, Saroglitazar Mg received approval for the treatment of NASH and NAFLD
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
Lupin gets tentative nod from US FDA for apalutamide tablets
This product will be manufactured at Lupin’s Pithampur facility in India
Lupin acquires five brands from Menarini
The brands are Piclin (Picosulphate Sodium), Menoctyl (Otilonium Bromide), Sucramal O (Sucralfate + Oxetacaine), Pyridium…
Lupin partners with Cost Plus Drugs, COPD Foundation
The collaboration seeks to expand availability of Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, to COPD patients in the US…
Lupin receives approval from USFDA for Pirfenidone tablets
This product will be manufactured at Lupin’s Pithampur facility in India
Lupin gets US FDA nod for Bromfenac Ophthalmic Solution, 0.09%; Metoprolol Succinate ER Tablets USP
Both products will be manufactured at Lupin’s Pithampur facility in India
Lupin gets US FDA approval for Doxycycline Hyclate Delayed-Release Tablets USP
This product will be manufactured at Lupin’s Pithampur facility in India
Lupin US FDA approval for Fluocinolone Acetonide Topical Oil
This product will be manufactured at Lupin’s Somerset facility in the US
Lupin gets US FDA approval for Norgestrel and Ethinyl Estradiol Tablets USP
This product will be manufactured at Lupin’s Pithampur facility in India.
Lupin announces resolution of USFDA warning letter for its two facilities
This is after the satisfactory evaluation of the corrective actions taken by the company in response to the warning letter that…